Current status and progress of fungal endophthalmitis treatment

Fungal endophthalmitis is a devastating infectious disease, with a poor visual prognosis and even possibility of eyeball enucleated. In recent years, the incidence of fungal endophthalmitis remarkably increased due to widely use of broad-spectrum antibiotics and corticosteroid hormone. This pose a c...

Full description

Saved in:
Bibliographic Details
Published inChung-hua yen k'o tsa chih Vol. 48; no. 11; p. 1041
Main Authors Wang, Shu-ran, Ye, Jun-jie
Format Journal Article
LanguageChinese
Published China 01.11.2012
Subjects
Animals
Antifungal Agents - therapeutic use
Endophthalmitis - drug therapy
Endophthalmitis - microbiology
Eye Infections, Fungal - drug therapy
Eye Infections, Fungal - microbiology
Humans
Online AccessGet more information

Cover

More Information
Summary:Fungal endophthalmitis is a devastating infectious disease, with a poor visual prognosis and even possibility of eyeball enucleated. In recent years, the incidence of fungal endophthalmitis remarkably increased due to widely use of broad-spectrum antibiotics and corticosteroid hormone. This pose a challenge to ophthalmologists and their capacity of treating fungal endophthalmitis need to be improved. It is necessary to introduce the present status and progress in fungal endophthalmitis treatment focus on medications, surgery and its etiological examination, especially the use of newer antifungal agents, including voriconazole and liposomal amphotericin B.
ISSN:0412-4081
DOI:10.3760/cma.j.issn.0412-4081.2012.11.023